Benlysta 400 mg powder for concentrate for solution for infusion | medicines.ie

Company: GlaxoSmithKline (Ireland) Ltd
Active Ingredient: Belimumab
Dosage Form: Powder for Solution for infusion
Legal Category: A - prescription, may not be renewed
Date of revision: 10/2026

*further information is available on request to the holder of the authorisation or in the SPC

Licence information is currently unavailable.

GlaxoSmithKline (Ireland) Ltd

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland, D24 Dublin

Telephone: +3531800244255